Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation
Clinical trial NCT01736527 · COMPLETED
Trial details
- NCT number
- NCT01736527
- Sponsor
- Bausch & Lomb Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.